EuroPCR 2026
Palais des Congrès Paris France | 19-22 May
Elevating Intelligence in Interventional Cardiology
- See how AI-boosted images are changing the game in interventional cardiology in our exclusive image experience room
- Learn about industry leading dose-reduction tools and advanced hemodynamic monitoring with QMAPP®
- Touch our new ergonomically designed 4D-TEE / Volume Matrix Transducer combined with AI-driven cardiology tools for Ultrasound
QMAPP® is a product of Fysicon, a Canon Group Company.
Visit us at Booth M39 | Hall Maillot (2F)
AI in Interventional Cardiology: Expanding Clinical Frontiers
Save the Date
Date: May 21, 2026 | 18:00-20:00
Venue: Le Méridien Paris Arc De Triomphe
Ternes Meeting Room 81 Bd Gouvion-Saint-Cyr 75017 Paris, France
Moderator: Mr. Glenn Isonc Radiographer, Senior Medical Radiation Scientist
Sydney, Australia
Sydney, Australia
Speaker: Prof. Tomasz Pawlowski Interventional cardiologist, Head of Catheterisation Laboratory,
Deputy Head of the Department of Cardiology
National Institute of Medicine of the Ministry of Internal
Affairs and Administration, Warsaw, Poland
Sydney, Australia
Title: “One Year of Experience With αEvolve Imaging for Cardiac and Structural Interventions”
Correct & sharp visualization in interventional cardiology is a key element for therapeutic procedures, especially during high-risk PCI and CTO cases. The presentation will cover data from more than 2000 patients treated with αEvolve Imaging, showing a huge reduction in X-ray dose.
Deputy Head of the Department of Cardiology
National Institute of Medicine of the Ministry of Internal
Affairs and Administration, Warsaw, Poland
Sydney, Australia
Title: “One Year of Experience With αEvolve Imaging for Cardiac and Structural Interventions”
Correct & sharp visualization in interventional cardiology is a key element for therapeutic procedures, especially during high-risk PCI and CTO cases. The presentation will cover data from more than 2000 patients treated with αEvolve Imaging, showing a huge reduction in X-ray dose.
Speaker: Assoc. Prof. Edward Danson Structural Interventional Cardiologist,
Department of Cardiology Wollongong Hospital,
Wollongong, NSW, Australia
Title: “AI in the Cath Lab: Practical Impact, Real Outcomes”
Presentation on the usage of new technologies, in particular how deep-learning trained imaging technologies are impacting interventional cardiology at a busy facility in Wollongong, Australia. Handling lengthy and potentially high-dose interventional cardiac procedures, integrating the latest technologies, including αEvolve Imaging, allows the opportunity to reduce radiation dose and move toward a DA-Less environment.
Department of Cardiology Wollongong Hospital,
Wollongong, NSW, Australia
Title: “AI in the Cath Lab: Practical Impact, Real Outcomes”
Presentation on the usage of new technologies, in particular how deep-learning trained imaging technologies are impacting interventional cardiology at a busy facility in Wollongong, Australia. Handling lengthy and potentially high-dose interventional cardiac procedures, integrating the latest technologies, including αEvolve Imaging, allows the opportunity to reduce radiation dose and move toward a DA-Less environment.
Our solutions for interventional cardiology
Alphenix / Evolve Edition
Interventional Cardiology departments are faced with increasing clinical demands, financial pressures, and the need for improved efficiency as the number and complexity of cases increase. To meet these challenges, we have introduced Alphenix / Evolve Edition.
Please accept marketing-cookies to watch this video.
Alphenix
Better integrated cardiac-optimized technologies help you deliver the best possible outcomes for your patients.
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
